MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$59,439K
Unrealized gain on
marketable securities
$412K
Interest income
$8,323K
Net loss
-$59,851K
Total other income
(expense)
$8,032K
Foreign currency loss
-$291K
Total loss from
operations
-$67,883K
Total operating
expenses
$67,883K
Research and development
expense
$46,713K
General and
administrative
$21,170K
Back
Back
Income Statement
source: myfinsight.com
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)